Connect with us

business

What’s The Deal with Shoddy Vape Carts Lately? 

Published

on


Living in Indiana, a very restrictive midwestern state, it’s not as easy to find cannabis products as it is in my home state of California. Not only that, but the price point is much higher here. In California, I can easily find an ounce of decent weed for $100, sometimes less, whereas the same quality of flower costs me $200 in Indiana. That also applies to vape carts, and since dispensaries are not a thing here, those are even harder to find.  

As a workaround, I often stock up on live resin carts in CA, which I can find for about $20-$30/gram. I’ve been doing this for years, but in the last few months, I’ve noticed a sharp decline in the quality of the carts I’m buying. And not in the concentrate that’s within the carts – that’s still perfectly fine – the problem is with the carts themselves.  

From some leaking to others completely falling apart, the majority of the vape carts I’ve bought in the last year (roughly 60 percent) have been subpar. Is cutting corners with shoddy manufacturing the new standard in a struggling cannabis industry?  

How vape carts are made  

A vape cart is a pre-filled glass cartridge containing some type of cannabis concentrate, such as distillate or live resin oil. Vape carts consist of three primary parts: the mouthpiece, the chamber, and the atomizer. The mouthpiece is the top part of the cart that allows the user to pull vapor out of the chamber. They are usually made from plastic, metal, or ceramic metal, and they can be attached to the chamber in a few different ways, either screwed in or with a fitted seal and some glue.  

The chamber is the largest part of the cart, sitting right in the middle between the mouthpiece and atomizer, and containing the concentrate. The chamber can vary in size, some holding only half a gram and others holding up to 3 grams of oil. Vape cart chambers are usually made from clear plastic, but sometimes Pyrex glass is used.  

And finally we have the atomizer, which is a metal or ceramic heating element attached to the bottom of the chamber which heats the concentrate and turns it into vapor. This is the portion of the cart that screws into the battery. Some atomizers are heated by the battery when a button is pushed. Others, like the ones attached to disposable batteries without a button, utilize a sensor that detects upwards airflow when the user inhales.  


Thank you for stopping in. Head over to the Cannadelics Weekly Newsletter for direct updates; and get access to awesome deals on cannabis buds, vapes, edibles, smoking devices and equipment, cannabinoid compounds, and some psychedelic products! Go get high responsibly!


Specific issues that I’ve noticed 

Unfortunately, I’ve had a variety of problems with my recent vape cart purchases ranging from mild and fixable, to complete failures that rendered the cart useless. First, let’s cover some of the milder problems. First, clogging. Almost all of my carts have clogged at some point, and this could be due in part to the fact that I prefer live resin, which is thicker than distillate. However, some of them got clogged to the point where no amount of sucking/inhaling would help. 

Another problem I had was leaking, where the live resin would leak out either through the mouthpiece or the atomizer. When it leaked through the mouthpiece, a couple of times I was able to wedge a small twig into the hole to plug it up and they continued working. But when it leaks out of the atomizer, there’s no way to fix it and it will end up leaking all over the battery and ruining that also.  

I’ve also had a couple of carts that completely fell apart, typically, the mouthpiece falls off and cannot be pushed back in. If more carts were made with mouthpieces that screwed in, this would not be an issue. A couple of time I had issues with the atomizer loosening as well, which again, led to concentrate leaking onto my battery.  

Why is this becoming more commonplace? 

When an industry is doing well, we see a few things that typically take place. Mainly, we see more job opportunities being created, a larger number of higher paying jobs and raises, and higher caliber products with quality design/engineering. Lately in the cannabis industry, we’re seeing the complete opposite; and the issues are global and ongoing.  

Some of the main problems we’ve been seeing stem from cannabis’ status as a schedule 1 controlled substance. Because of extremely high licensing and real estate fees, lack of access to traditional financial services, and the highly competitive nature of the cannabis industry, very few growers/retailers/processors are in the black right now. This has led to a wide array of problems from cheaper equipment being used to falsified lab reports, mass layoffs in the industry, and more.

When an industry begins cutting corners on a larger, more widespread scale, often the ones who gets the screwed the most in these scenarios are the consumers, because they are now receiving a subpar product for the same price that they used to pay for something decent.  

Case in point, I’ve been buying vape carts for years and never had as many issues with them as I have over the last few months. I also asked a few other friends who vape and they complained of similar problems, so it’s not just me being unlucky, the problem is becoming widespread. To the extent that some dispensaries are even offering insurance coverage for vape carts, so in the event that it breaks, you can mail it into the manufacturer for a refund or replacement. But since most of these carts are relatively cheap and that sounds like a bit of unneeded hassle, they’re likely banking on the fact that most people won’t be doing this.  

Despite how doom and gloom as all the above may sound, it’s really not all that bleak. As someone who attends conventions regularly, those are still very busy which is a great indication that industry professionals are seeing some profits and remaining hopeful. Also, more states are legalizing cannabis, the federal government likely will soon too, and new research on the benefits of using cannabinoids are still released on a regular basis. Many of the more established brands are companies are still holding strong as well. So, even though we’re seeing some issues, that doesn’t mean things can’t be turned around eventually.

Final thoughts

Since I haven’t seen this discussed anywhere in any serious capacity, I figured I would throw it out there to see if any of our readers are having similar dilemmas. Have you noticed a growing number of problems with your vape carts lately? If so, drop us a line in the comment section below, we’d love to get some more opinions on this!

Hello and welcome! Thanks for making your way to Cannadelics.com; a news platform where we work hard to bring you the utmost in reporting for the cannabis and psychedelics spaces. Chill with us daily to stay up-to-date, and sign up for the Cannadelics Weekly Newsletter, to ensure you’re always up on what’s going down.



Source link

Continue Reading

business

Marijuana rescheduling leaves regulators and sellers cautiously optimistic

Published

on

By



A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana advocates alike.

The Drug Enforcement Agency will drop marijuana from the list of banned substances found under Schedule I of the Controlled Substances Act, where it currently sits alongside heroin and LSD. It will instead move it to Schedule III, among the likes of Tylenol with codeine and anabolic steroids. This follows the recommendation of the Department of Health and Human Services

“Rescheduling cannabis is a monumental step forward for the federal government, one that can open new avenues to research, medical use, and banking for the regulated industries states like Massachusetts have built across the country,” said Ava Callender Concepcion, the acting chair of the Bay State’s Cannabis Control Commission.

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

business

Thailand Considers Relisting Cannabis as a Narcotic

Published

on

By


The Thai government is contemplating the relisting of cannabis as a narcotic due to concerns over its recreational use and potential societal harms. This reconsideration comes after cannabis was decriminalized in June 2022, which led to a surge in its availability and use.

Cannabis Conundrum: Thailand Reconsiders Legal Status Amidst Rising Concerns

The recent decriminalization of cannabis in Thailand has ignited a complex debate over its legal status and societal impact. While the policy aimed to boost the medical marijuana industry and provide economic opportunities, the unintended rise in recreational use has sparked discussions about a potential reclassification.

Public Health Minister Anutin Charnvirakul, a key advocate for the decriminalization, emphasized that the policy was intended to promote medical use, not recreational. However, the current legal framework lacks clear regulations governing recreational use, leading to widespread availability and potential misuse.

The Bhumjaithai Party, led by Anutin, initially pushed for the delisting of cannabis to benefit the medical industry and provide economic opportunities for Thai citizens. However, the subsequent surge in recreational use, particularly among youths, has raised concerns about potential health and social consequences.

Opposition parties have criticized the government for inadequate regulations and are advocating for cannabis to be relisted as a narcotic under the Narcotics Act. They argue that the current situation exposes young people to potential harm and lacks sufficient safeguards.

A recent poll revealed that a majority of Thais support stricter regulations on cannabis use. Concerns have been raised about the potential impact on public health, particularly regarding mental health issues and addiction, especially among youths. Additionally, there are worries about the potential for increased crime and social disorder.

The government now faces the challenge of balancing the economic benefits of a burgeoning cannabis industry with the need to protect public health and safety. Finding a solution that addresses the concerns of both advocates and critics will be crucial in determining the future of cannabis in Thailand

Why It Matters

Thailand’s shift in cannabis policy has garnered international attention, serving as a case study for the complexities of drug policy reform. The potential reclassification of cannabis underscores the challenges of balancing economic opportunities with public health and safety considerations. The outcome of this debate will have significant implications for Thailand’s legal landscape, public health policies, and the future of its cannabis industry.

Potential Implications of Relisting Cannabis as a Narcotic

If cannabis is relisted as a narcotic, it could lead to stricter regulations on its cultivation, distribution, and use. This may impact the growth of the medical marijuana industry and limit access for patients who rely on cannabis for therapeutic purposes. Additionally, it could result in increased criminal penalties for possession and use, potentially leading to a rise in incarceration rates.

Alternatively, if the government opts to maintain the decriminalized status, it will need to implement robust regulations and public health campaigns to mitigate the risks associated with recreational use. This includes age restrictions, educational initiatives, and support systems for individuals struggling with cannabis dependence.

The Bigger Picture

The debate surrounding cannabis legalization and regulation is a global phenomenon, with countries around the world grappling with similar challenges. The Thai government’s decision regarding cannabis will likely be influenced by international trends and best practices in drug policy reform. It is crucial to consider the experiences of other nations that have legalized or decriminalized cannabis, examining both the successes and challenges they have encountered.

Source: Thai PBS World



Source link

Continue Reading

banking

“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabis

Published

on

By



Cannabis advocates in Colorado cheered the Biden Administration’s reported move to reclassify marijuana and said the decision likely would reduce businesses’ tax burden significantly.

Industry leaders cautioned that such a move — if finalized — would not resolve some major challenges facing the industry, such as limited access to banking. But they pointed to the symbolic importance of preparations by the U.S. Drug Enforcement Administration to downgrade the substance’s drug classification.

A man pours cannabis into rolling papers as he prepares to roll a joint the Mile High 420 Festival in Civic Center Park in Denver, April 20, 2024. (Photo by Kevin Mohatt/Special to The Denver Post)

Read the rest of this story on DenverPost.com.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media